AAAAAA
Results: 26-39/39
Authors:
Rodes, B
Holguin, A
Soriano, V
Dourana, M
Mansinho, K
Antunes, F
Gonzalez-Lahoz, J
Citation: B. Rodes et al., Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy, J CLIN MICR, 38(4), 2000, pp. 1370-1374
Authors:
Dona, C
Soriano, V
Barreiro, P
Jimenez-Nacher, I
Gonzalez-Lahoz, J
Citation: C. Dona et al., Toxicity associated to efavirenz in HIV-infected persons enrolled in an expanded access program, MED CLIN, 115(9), 2000, pp. 337-338
Authors:
Martin, JC
Fernandez, P
Soriano, V
Martinez, P
Gonzalez-Lahoz, J
Citation: Jc. Martin et al., Viral load and CD4+lymphocyte count in the highly active antiretroviral therapy era, MED CLIN, 115(3), 2000, pp. 118-118
Authors:
Puente, S
Rubio, JM
Subirats, M
Lago, M
Gonzalez-Lahoz, J
Benito, A
Citation: S. Puente et al., The use of PCR in the diagnosis of hyper-reactive malarial splenomegaly (HMS), ANN TROP M, 94(6), 2000, pp. 559-563
Authors:
de Mendoza, C
Soriano, V
Perez-Olmeda, M
Rodes, B
Casas, E
Gonzalez-Lahoz, J
Citation: C. De Mendoza et al., Different outcomes in patients achieving complete or partial viral load suppression on antiretroviral therapy, J HUMAN VIR, 2(6), 1999, pp. 344-349
Authors:
Rodriguez-Rosado, R
Soriano, V
Blanco, F
Dona, C
Gonzalez-Lahoz, J
Citation: R. Rodriguez-rosado et al., Diabetes mellitus associated with protease inhibitor use, EUR J CL M, 18(9), 1999, pp. 675-677
Authors:
de Mendoza, C
Soriano, V
Gonzalez-Lahoz, J
Citation: C. De Mendoza et al., Association between submaximal suppression of HIV replication and use of drug combinations without protease inhibitors, EUR J CL M, 18(8), 1999, pp. 604-605
Authors:
Soriano, V
Garcia-Samaniego, J
Valencia, E
Rodriguez-Rosado, R
Munoz, F
Gonzalez-Lahoz, J
Citation: V. Soriano et al., Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users, EUR J EPID, 15(1), 1999, pp. 1-4
Authors:
de Mendoza, C
Soriano, V
Rodriguez-Rosado, R
Gonzalez-Lahoz, J
Citation: C. De Mendoza et al., Higher antiviral activity of antiretroviral regimens including protease inhibitors, AIDS, 13(8), 1999, pp. 998-999
Authors:
Anton, P
Soriano, V
Jimenez-Nacher, I
Rodriguez-Rosado, R
Dona, MC
Barreiro, PM
Gonzalez-Lahoz, J
Citation: P. Anton et al., Incidence of rash and discontinuation of nevirapine using two different escalating initial doses, AIDS, 13(4), 1999, pp. 524-525
Authors:
Rodriguez-Rosado, R
Soriano, V
Barreiro, P
Dona, C
Gonzalez-Lahoz, J
Citation: R. Rodriguez-rosado et al., What dual protease inhibitor combination for salvage therapies?, AIDS, 13(15), 1999, pp. 2180-2181
Authors:
Gordillo, V
del Amo, J
Soriano, V
Gonzalez-Lahoz, J
Citation: V. Gordillo et al., Sociodemographic and psychological variables influencing adherence to antiretroviral therapy, AIDS, 13(13), 1999, pp. 1763-1769
Authors:
Weverling, GJ
Mocroft, A
Ledergerber, B
Kirk, O
Gonzalez-Lahoz, J
Monforte, AD
Proenca, R
Phillips, AN
Lundgren, JD
Reiss, P
Citation: Gj. Weverling et al., Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection, LANCET, 353(9161), 1999, pp. 1293-1298
Authors:
Rodriguez-Rosado, R
Soriano, V
Dona, C
Gonzalez-Lahoz, J
Citation: R. Rodriguez-rosado et al., Opportunistic infections shortly after beginning highly active antiretroviral therapy, ANTIVIR TH, 3(4), 1998, pp. 229-231